Wordt geladen...
SHP2: a new target for pro-senescence cancer therapies
Cellular senescence is a response to stress that disables cell proliferation and orchestrates an inflammatory process that eliminates damaged cells. The first pro-senescence drugs for cancer treatment are now a clinical reality, but still few targets have been identified whose inactivation results i...
Bewaard in:
| Gepubliceerd in: | EMBO J |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BlackWell Publishing Ltd
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4474521/ https://ncbi.nlm.nih.gov/pubmed/25916826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.201591616 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|